Agilent Technologies, Inc. (A)
A Price and Sentiment
A Latest news
Agilent Technologies (A) Dips More Than Broader Markets: What You Should Know
2021-11-09 19:49Agilent Technologies (A) closed the most recent trading day at $159.81, moving -0.7% from the previous trading session.
Agilent Technologies (A) Outpaces Stock Market Gains: What You Should Know
2021-11-02 19:09Agilent Technologies (A) closed the most recent trading day at $157.85, moving +0.5% from the previous trading session.
Agilent Names John Palma to Lead Global Medical Affairs Organization
2021-11-02 14:00SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent has named John Palma vice president of Medical Affairs.
Why the Earnings Surprise Streak Could Continue for Agilent (A)
2021-11-01 13:49Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
2021-11-01 08:06SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today the new Agilent 6560C Ion Mobility LC/Q-TOF, enhancements to the VWorks automation software suite, and new AssayMAP large capacity cartridges. These solutions will be on show at the American Society for Mass Spectrometry Conference (ASMS) which is being held October 31 - November 4, 2021, in Philadelphia, PA. These products improve the analysis of proteins and peptides to speed up the development of new pr
Stocks This Week: Buy ProShares Ultra QQQ And Agilent Technologies
2021-10-31 15:35Here are trading recommendations for this coming strong week.
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
2021-10-28 16:47SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labelled for use in TNBC in the European Union. PD-L1 expression is a critical biomarker for response to anti-PD-1 therapies such as KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy manufactured by Merck (known as MSD outside the United States and Canada). The expanded use of PD-L1 IHC 22C3 pharmDx strengthens the ability of pathologists to identify patients who
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
2021-10-28 16:05SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to webcast fourth quarter fiscal year 2021 financial results Monday, November 22.
Agilent Technologies (A) Dips More Than Broader Markets: What You Should Know
2021-10-27 19:26In the latest trading session, Agilent Technologies (A) closed at $155.26, marking a -1.85% move from the previous day.
Agilent Commits to Net-Zero Greenhouse Gas Emissions by 2050
2021-10-27 08:00SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies, Inc. (NYSE: A) today announced its commitment to achieve net-zero greenhouse gas emissions no later than 2050. The commitment adds to the global effort by governments, corporations, and other institutions to limit warming of the climate to 1.5°C above pre-industrial levels, a goal of the 2015 Paris Agreement on climate change. To ensure the company achieves its net-zero goals, Agilent has also committed to interim greenhouse gas reduct